Inventor
SHAW PETER
US22 patents
⚠️ This page may combine multiple inventors who share the name “SHAW PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTHOMER UK LTD
5 patentsUS12098228B2Sep 24, 2024
Polymer latex and elastomeric film made therefrom having self-healing properties
SYNTHOMER UK LTD0 citations54
US12234334B2Feb 25, 2025
Self-supported elastomeric film having self-healing properties made from a polymer latex
SYNTHOMER UK LTD0 citations50
US10711073B2Jul 14, 2020
Method of making a branched polymer, a branched polymer and uses of such a polymer
SYNTHOMER UK LTD0 citations37
US10106635B2Oct 23, 2018
Secondary suspending agent for suspension polymerisation reaction
SYNTHOMER UK LTD0 citations30
US10647793B2May 12, 2020
Use of a sulphur or phosphorous-containing polymer as a processing aid in a polyvinyl chloride polymer composition
SYNTHOMER UK LTD0 citations28
BRISTOL MYERS SQUIBB CO
3 patentsUS7932031B2Apr 26, 2011
Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1
BRISTOL MYERS SQUIBB CO12 citations80
US7537891B2May 26, 2009
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
BRISTOL MYERS SQUIBB CO8 citations80
US7504211B2Mar 17, 2009
Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
BRISTOL MYERS SQUIBB CO3 citations59
CELERA CORP
3 patentsUS9932637B2Apr 3, 2018
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
CELERA CORP2 citations69
US11708610B2Jul 25, 2023
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
CELERA CORP0 citations58
US10982281B2Apr 20, 2021
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
CELERA CORP0 citations58